Profit announcement! Top 70 domestic arms companies are coming (with list)

In the first half of 2020, a global outbreak of the new crown outbreak has made some medical device countries in urgent need of supplies, ranging from CTs and ventilators to masks and thermostats.
the test of this outbreak, the pattern of domestic and international markets began to reshuffle.
the international market has been at the peak of the epidemic since the beginning of March, from the beginning of the developed countries in Europe and the United States gradually spread to developing countries, major companies related to the production capacity and delivery of anti-epidemic equipment after March began to tilt towards the international market.
With the epidemic prevention and control into normal, the state has introduced relevant policies to improve China's epidemic prevention and control and public health emergency system, strengthen basic research in the field of life sciences and key core technological breakthroughs in medical health, accelerate the improvement of epidemic prevention and control and public health strategic scientific and technological strength and strategic reserve capacity, speed up the replacement of China's high-end medical equipment short board.
The National Development and Reform Commission and the Health and Safety Commission have issued the Capacity Building Program for Public Health Prevention and Control and the Notice on Improving the Prevention and Control of Infections in Fever Clinics and Medical Institutions, pointing out that the modernization of the disease prevention and control system, the overall upgrading of the capacity of county-level hospitals, the improvement of the urban infectious disease treatment network, the transformation and upgrading of major epidemic treatment bases, and the promotion of the rehabilitation of public facilities for both use; Intensive care area (ICU), respiratory, infection and other departments, the configuration of bedside monitoring system, ventilators, in-body membrane pulmonary oxygenation (ECMO), polymerase chain reactor (PCR) and other equipment, to further strengthen public health construction, and do a good job in filling the board, plug loopholes, strengths and weaknesses.
On July 30, 2020, the Ministry of Finance issued the Notice on the Release of the Budget for Subsidies for the Construction of the Emergency Materials Support System, focusing on improving the capacity of public health emergency materials production mobilization, supporting state-owned and private enterprises to carry out the necessary capacity backup construction and enhancing the capacity of emergency production, and forming a sustainable supply capacity for medical materials and equipment.
the second half of 2020 is still an important period for the rapid improvement of medical devices, the first half of the results are the cornerstone and history, need to sum up the experience before starting.
, profit ranking in the first half of 2020 domestic A-share listed enterprises overall rose.
end of August 2020, the total revenue of 71 domestic A-share enterprises was 83.5 billion yuan, up about 44% YoY, and the total net profit was 22.66 billion yuan, up 34% YoY.
first half of this year, there were 21 arms enterprises, revenue of more than 1 billion yuan.
in terms of revenue growth, Sanxiang Bio was the fastest, at 1159.4%, Anglo Medical was growing by more than 300%, and Seven arms companies, such as Jianfan Bio, were growing by more than 100%.
but 25 companies fell.
the company ranked first in net profit of 3,454 million yuan, while Sanxiang, Lepu and Fish Leap all posted net profits of more than 1 billion yuan.
but four lost money on net profit.
of the first places is as follows